Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Francesca Del Monte"'
Autor:
Emanuela Risi, Camilla Lisanti, Alessia Vignoli, Chiara Biagioni, Agnese Paderi, Silvia Cappadona, Francesca Del Monte, Erica Moretti, Giuseppina Sanna, Luca Livraghi, Luca Malorni, Matteo Benelli, Fabio Puglisi, Claudio Luchinat, Leonardo Tenori, Laura Biganzoli
Publikováno v:
Translational Oncology, Vol 27, Iss , Pp 101585- (2023)
Background: We previously showed that metabolomics predicts relapse in early breast cancer (eBC) patients, unselected by age. This study aims to identify a “metabolic signature” that differentiates eBC from advanced breast cancer (aBC) patients,
Externí odkaz:
https://doaj.org/article/f501718a1b814d1ea3d04989480cb89f
Autor:
Alessia Vignoli, Elena Mori, Samantha Di Donato, Luca Malorni, Chiara Biagioni, Matteo Benelli, Vanessa Calamai, Stefano Cantafio, Annamaria Parnofiello, Maddalena Baraghini, Alessia Garzi, Francesca Del Monte, Dario Romagnoli, Ilenia Migliaccio, Claudio Luchinat, Leonardo Tenori, Laura Biganzoli
Publikováno v:
Applied Sciences, Vol 11, Iss 23, p 11120 (2021)
Background: Colorectal cancer (CRC) is the fourth most commonly diagnosed and third most deadly cancer worldwide. Surgery is the main treatment option for early disease; however, a relevant proportion of CRC patients relapse. Here, variations among p
Externí odkaz:
https://doaj.org/article/a93d6efcf0ca42219c2175a320e56715
Autor:
Stuart H Ralston, André G Uitterlinden, Maria Luisa Brandi, Susana Balcells, Bente L Langdahl, Paul Lips, Roman Lorenc, Barbara Obermayer-Pietsch, Serena Scollen, Mariona Bustamante, Lise Bjerre Husted, Alisoun H Carey, Adolfo Diez-Perez, Alison M Dunning, Alberto Falchetti, Elzbieta Karczmarewicz, Marcin Kruk, Johannes P. T. M van Leeuwen, Joyce B. J van Meurs, Jon Mangion, Fiona E. A McGuigan, Leonardo Mellibovsky, Francesca del Monte, Huibert A. P Pols, Jonathan Reeve, David M Reid, Wilfried Renner, Fernando Rivadeneira, Natasja M van Schoor, Rachael E Sherlock, John P. A Ioannidis
Publikováno v:
PLoS Medicine, Vol 3, Iss 5 (2006)
Externí odkaz:
https://doaj.org/article/d533184ce5314ba9985c7ffd9b2c1be5
Autor:
Stuart H Ralston, André G Uitterlinden, Maria Luisa Brandi, Susana Balcells, Bente L Langdahl, Paul Lips, Roman Lorenc, Barbara Obermayer-Pietsch, Serena Scollen, Mariona Bustamante, Lise Bjerre Husted, Alisoun H Carey, Adolfo Diez-Perez, Alison M Dunning, Alberto Falchetti, Elzbieta Karczmarewicz, Marcin Kruk, Johannes P T M van Leeuwen, Joyce B J van Meurs, Jon Mangion, Fiona E A McGuigan, Leonardo Mellibovsky, Francesca del Monte, Huibert A P Pols, Jonathan Reeve, David M Reid, Wilfried Renner, Fernando Rivadeneira, Natasja M van Schoor, Rachael E Sherlock, John P A Ioannidis, GENOMOS Investigators
Publikováno v:
PLoS Medicine, Vol 3, Iss 4, p e90 (2006)
BackgroundOsteoporosis and fracture risk are considered to be under genetic control. Extensive work is being performed to identify the exact genetic variants that determine this risk. Previous work has suggested that a G/T polymorphism affecting an S
Externí odkaz:
https://doaj.org/article/d104a86c6a92461b932122e123dbc392
Autor:
Sandro Pignata, Giovanni Scambia, Clorinda Schettino, Laura Arenare, Carmela Pisano, Davide Lombardi, Ugo De Giorgi, Claudia Andreetta, Saverio Cinieri, Carmine De Angelis, Domenico Priolo, Claudia Casanova, Marta Rosati, Filippo Greco, Elena Zafarana, Ilaria Schiavetto, Serafina Mammoliti, Sabrina Chiara Cecere, Vanda Salutari, Simona Scalone, Alberto Farolfi, Marilena Di Napoli, Domenica Lorusso, Piera Gargiulo, Daniela Califano, Daniela Russo, Anna Spina, Rossella De Cecio, Paolo Chiodini, Francesco Perrone, Valentina Accinno, Chiara Altavilla, Giovanna Antonelli, Grazia Artioli, Francesco Avola, Bonifacio Barbara, Valentina Barbato, Michele Bartoletti, Simona Bevilacqua, Roberto Bordonaro, Oriana Borghese, Gaetano Buonfanti, Floriana Camarda, Giuliana Canzanella, Vittoria Carbone, Maria Rita Carbone, Giulia Carlo Stella, Chiara Cassani, Fabrizio Castagna, Monica Cattaneo, Margherita Cinefra, Nicoletta Colombo, Serena Corsetti, Monia Dall'Agata, Maria D'Amico, Gennaro Daniele, Elvira De Marino, Giovanni De Matteis, Sabino De Placido, Gabriella Del Bene, Antonia Del Giudice, Francesca Del Monte, Michele Del Sesto, Maddalena Donini, Giuliana Drudi, Gianluca Falcone, Adolfo Favaretto, Giulia Ferrera, Manuela Florio, Valeria Forestieri, Maria Stella Gallo, Ciro Gallo, Francesca Garibaldi, Fabiana Gerevini, Viola Ghizzoni, Maria Olga Giganti, Anna Gimigliano, Elena Giudice, Nicoletta Gnocchi, Adriano Gravina, Stefano Greggi, Maria Laura Iaia, Annalisa Ilardi, Gelsomina Iovine, Gabriella Ippoliti, Giulia Irollo, Ilenia Isidori, Mariateresa Lapresa, Giuseppe Lavenia, Laura Longhitano, Bortot Lucia, Gabriella Luzi, Sara Mariano, Valentina Marino, Giovanna Marrapese, Marilena Martino, Roberta Matocci, Enrica Mazzoni, Daniela Mercuri, Maria Mirto, Giovanna Mollo, Abbondanza Montinaro, Marta Moscatelli, Anna Maria Mosconi, Lucia Musacchio, Nicoletta Nanni, Pamela Natalucci, Milena Sabrina Nicoloso, Michele Orditura, Gabriella Maria Parma, Rodolfo Passalacqua, Michela Pelone, Maria Teresa Perri, Bruno Perrucci, Alessandra Piancastelli, Maria Carmela Piccirillo, Antonio Piccolo, Stefania Rapisardi, Giorgia Ravaglia, Teresa Ribecco, Caterina Ricci, Marianna Roccio, Fiorella Romano, Daniela Sambataro, Alfonso Savio, Ada Sbriglia, Cono Scaffa, Concetta Sergi, Francesca Sgandurra, Roberto Sorio, Stefano Stabile, Gianna Tabaro, Margherita Tambaro, Stefano Tamberi, Angelica Tecchiato, Angela Maria Trujillo, Eleonora Zaccarelli
Publikováno v:
The Lancet Oncology. 24:286-296
Background: Adding immunotherapy to first-line chemotherapy might improve outcomes for patients with advanced or recurrent endometrial cancer. We aimed to compare carboplatin and paclitaxel versus avelumab plus carboplatin and paclitaxel as first-lin
Autor:
Emanuela Risi, Camilla Lisanti, Alessia Vignoli, Chiara Biagioni, Agnese Paderi, Silvia Cappadona, Francesca Del Monte, Erica Moretti, Giuseppina Sanna, Luca Livraghi, Luca Malorni, Matteo Benelli, Fabio Puglisi, Claudio Luchinat, Leonardo Tenori, Laura Biganzoli
Publikováno v:
Translational oncology. 27
We previously showed that metabolomics predicts relapse in early breast cancer (eBC) patients, unselected by age. This study aims to identify a "metabolic signature" that differentiates eBC from advanced breast cancer (aBC) patients, and to investiga
Autor:
Matteo Benelli, Elena Mori, Laura Biganzoli, Dario Romagnoli, Stefano Cantafio, Maddalena Baraghini, Francesca Del Monte, Samantha Di Donato, Luca Malorni, Ilenia Migliaccio, Leonardo Tenori, V. Calamai, Alessia Vignoli, Chiara Biagioni, Alessia Garzi, Claudio Luchinat, A. Parnofiello
Publikováno v:
Applied Sciences, Vol 11, Iss 11120, p 11120 (2021)
Applied Sciences; Volume 11; Issue 23; Pages: 11120
Applied Sciences; Volume 11; Issue 23; Pages: 11120
Background: Colorectal cancer (CRC) is the fourth most commonly diagnosed and third most deadly cancer worldwide. Surgery is the main treatment option for early disease; however, a relevant proportion of CRC patients relapse. Here, variations among p
Autor:
V. Calamai, Laura Biganzoli, A. Parnofiello, Alessia Vignoli, Elisangela Miceli, Angelo Di Leo, Luca Malorni, Elena Mori, Giuseppe Mottino, Ilenia Migliaccio, Leonardo Tenori, Maddalena Baraghini, Samantha Di Donato, Stefano Cantafio, Dimitri Becheri, Francesca Del Monte, Chiara Biagioni, Amelia McCartney, Giulia Di Pierro, Claudio Luchinat
Publikováno v:
Cancers
Volume 13
Issue 11
Cancers, Vol 13, Iss 2762, p 2762 (2021)
Volume 13
Issue 11
Cancers, Vol 13, Iss 2762, p 2762 (2021)
Simple Summary Around 30–40% of patients with early stage colorectal cancer (eCRC) experience relapse after surgery. Current recommendations for adjuvant therapy are based on suboptimal risk-stratification tools. In elderly patients, risk of relaps
Autor:
Claudio Luchinat, Matteo Benelli, Daniele Pozzessere, Francesca Del Monte, Veronica Ghini, Letizia Laera, Beatrice Fantechi, Amelia McCartney, Tenori Leonardo
Publikováno v:
Cancers
Volume 12
Issue 12
Cancers, Vol 12, Iss 3574, p 3574 (2020)
Volume 12
Issue 12
Cancers, Vol 12, Iss 3574, p 3574 (2020)
In the treatment of advanced non-small cell lung cancer (NSCLC), immune checkpoint inhibitors have shown remarkable results. However, not all patients with NSCLC respond to this drug treatment or receive durable benefits. Thus, patient stratification
Autor:
Giuseppe Colloca, Francesca Del Monte, Paolo Foa, B. Castagneto, Laura Biganzoli, Silvio Monfardini, Daris Ferrari, Lorenzo Dottorini, Nicolò Matteo Luca Battisti, Francesca Galli, Pasquale Fiduccia, Irene Floriani, Elena Zafarana, Andrea Luciani, Cristina Falci
Publikováno v:
Journal of Geriatric Oncology. 6:272-279
Some parameters of the Comprehensive Geriatric Assessment (CGA) are predictive of chemotherapy toxicity. The Vulnerable Elders Survey-13 (VES-13) is a short instrument that has been tested as a means of identifying patients who need a full CGA, but i